Prestige Biopharma Successfully Concludes ‘Prestige Symposium’ on Aging

Held on September 4 under the theme “Latest Trends in the Mechanisms of Aging and Age-Related Diseases,” the symposium was designed to connect fundamental research on the mechanisms of aging with therapeutic development strategies, while providing a platform to share the latest research findings and emerging treatment approaches.

In the keynote lecture, Dr. Arthur Levin presented recent advances and the potential of oligonucleotide therapeutics, highlighting new approaches that could be applied to the treatment of age-related diseases.

The subsequent sessions featured presentations by Professor Hae Young Chung of Pusan National University, Professor Seung-Jae Lee of KAIST, Professor JinHo Yoon of Dong-A University, Principal Researcher HoYoung Lee of Syntekabio, Professor Chanhee Kang of Seoul National University, Professor Dongryeol Ryu of GIST, Professor JaeWon Lee of Pusan National University, and Ki Sun Kwon, CEO of Aventi. The speakers shared their latest findings in aging-related research and discussed strategies for translating scientific discoveries into therapeutic development.

Sang Seok Koh, CEO of Prestige Biopharma IDC, said, “This symposium was particularly meaningful as it brought together a wide range of research findings, from the fundamental mechanisms of aging to their application in new drug development, while providing an opportunity to explore new therapeutic possibilities.”

He added, “We will continue to expand collaboration with researchers and industry partners in Korea and abroad, strengthening the foundation for translating advances in aging research into innovative therapies.”

Source: Asia Economy(https://view.asiae.co.kr/article/2026090809434043827)